[HTML][HTML] Can we use eplets (or molecular) mismatch load analysis to improve organ allocation? The hope and the hype
In recent years, there have been calls for implementation of “epitope matching” in deceased-
donor organ allocation policies (later changed to “eplet matching”). Emerging data indeed …
donor organ allocation policies (later changed to “eplet matching”). Emerging data indeed …
Pediatric kidney transplantation—Can we do better? The promise and limitations of Epitope/Eplet matching
O Charnaya, D Levy Erez, S Amaral… - Frontiers in Pediatrics, 2022 - frontiersin.org
Kidney transplant is the optimal treatment for end-stage kidney disease as it offers significant
survival and quality of life advantages over dialysis. While recent advances have …
survival and quality of life advantages over dialysis. While recent advances have …
Combined Analysis of HLA Class II eplet mismatch and tacrolimus levels for the prediction of de novo donor specific antibody development in kidney transplant …
We investigated whether HLA class II eplet mismatch was related to dnDSA development
and analyzed its combined impact with tacrolimus levels for kidney transplantation …
and analyzed its combined impact with tacrolimus levels for kidney transplantation …
HLA B eplet mismatches in the context of delayed graft function and low tacrolimus trough levels are risk factors influencing the generation of de novo donor-specific …
S Gao, H Gong, M Li, P Lan, M Zhang, P Kuang… - Transplant …, 2023 - Elsevier
Background De novo donor-specific antibody (dnDSA) generation and acute rejection (AR)
are the main factors affecting long-term graft survival. This study aims to investigate human …
are the main factors affecting long-term graft survival. This study aims to investigate human …